Chapter 34
Targeted kinase inhibitors, monoclonal antibodies, antibody-drug conjugates, immune checkpoint inhibitors, hormonal oncology, and CAR-T cell therapy.
Modules & Question Sets
Module 1
BCR-ABL, EGFR, and ALK/ROS1 Kinase Inhibitors
Module 2
Targeted Small Molecule Inhibitors
Module 3
Monoclonal Antibodies and Antibody-Drug Conjugates
Module 4
Immune Checkpoint Inhibitors and Hormonal Oncology